Equity Overview
Price & Market Data
Price: $1.71
Daily Change: -$0.04 / 2.34%
Daily Range: $1.70 - $2.13
Market Cap: $59,477,248
Daily Volume: 2,902,085
Performance Metrics
1 Week: -1.69%
1 Month: 5.42%
3 Months: -4.89%
6 Months: -16.67%
1 Year: -38.60%
YTD: -59.11%
Company Details
Employees: 4
Sector: Health technology
Industry: Biotechnology
Country:
Details
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.